
A $300M industrial manufacturer
Rebuilding margin at a mid-market industrial manufacturer
Expanded EBITDA margin by 320 basis points in 18 months.
320 bpsEBITDA margin expansion
$22MAnnualized cost out
18 moTo full run-rate
A regional medtech firm
Accelerated time-to-market by 30% with a redesigned, data-driven stage-gate.
A medtech firm’s product-development pipeline was slow and opaque. Projects stalled in an overloaded stage-gate, and leadership had no real-time view of where value was stuck.
Time-to-market improved 30% and stalled projects fell sharply, with a data-driven stage-gate the organization now uses as its default operating rhythm.

Expanded EBITDA margin by 320 basis points in 18 months.

Grew revenue 22% in two years by entering two adjacent segments.
A confidential, no-pressure conversation with a partner — not a pitch. We’ll listen, share how we’d think about it, and propose a scope and fixed fee only if there’s a fit.